The marketing, from what I’ve seen of it seems to be a private healthcare model issue, not something you see a lot of in Europe. You can do regulation on that kind of stuff without banning R&D.
I can assure you, the UK at least will be falling over itself to pick up whatever it can if the US stops. I imagine much of the EU will as well.